Browsing Category
Pharma Industry News
4730 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Vaximm AG advances VXM01 strategy with BCM Europe term sheet offering US$20m upfront and US$815m upside
Learn how Vaximm AG’s new term sheet with BCM Europe sets the stage for a US$20M upfront license deal and up to US$815M in milestones.
XOMA Royalty completes LAVA Therapeutics acquisition in push to strengthen bispecific antibody pipeline
Find out how XOMA Royalty’s acquisition of LAVA Therapeutics strengthens its oncology royalty portfolio and expands its partnered bispecific antibody programs.
Why Eli Lilly (NYSE: LLY) just joined the $1tn club—and what it means for obesity drug stocks
Find out how Eli Lilly’s weight-loss drug surge has pushed it past a $1 trillion valuation—and what that means for the industry!
Sangamo Therapeutics shares surge 13% after FDA accepts rolling BLA for ST‑920 in Fabry disease
Sangamo Therapeutics shares surged 13% as the FDA accepted a rolling BLA for ST‑920 in Fabry disease. Learn what this milestone means and what’s next.
Contineum Therapeutics (NASDAQ: CTNM) shares slump after PIPE-307 fails to show efficacy in multiple sclerosis trial
PIPE-307 failed to meet efficacy endpoints in RRMS Phase 2, sending Contineum Therapeutics stock lower. Find out what’s next for PIPE-791 and MDD.
Why Inhibikase Therapeutics (NASDAQ: IKT) is tapping public markets now for $100m in new funding
Find out how Inhibikase Therapeutics plans to use its $100M equity raise to fund pipeline trials and what it means for shareholders in 2025.
Hyrnuo secures FDA approval as Bayer expands precision oncology in HER2-driven lung cancer
FDA approval of Bayer’s Hyrnuo opens a new targeted option for HER2-mutated lung cancer patients—find out how this therapy is reshaping precision oncology today.
How Psyence BioMed’s new pharmaceutical-grade ibogaine supply chain reshapes addiction-therapy markets
Psyence Biomedical Ltd., PsyLabs, ibogaine, psychedelics, substance use disorder, pharmaceutical manufacturing
Plus Therapeutics wins major reimbursement milestone as Humana approves CNSide cerebrospinal fluid assay
Find out how Plus Therapeutics secured Humana’s national coverage for the CNSide assay and what it means for metastatic CNS cancer care today.
Abbott expands diagnostics empire with $23bn takeover of cancer-test leader Exact Sciences
Find out how Abbott’s $23B acquisition of Exact Sciences could reshape cancer diagnostics and redefine growth in oncology screening.